`
`
`
`
`
`@ Europe PMC Help|Europe PMCplusAbout Tools Developers
`
`
`
`& Signin | Create an account
`
`
`Search worldwide,life-sciencesliterature
`
`
`
`CITES:17960406_MED
`
`Coronavirus articles and preprints Search examples: "breast cancer" Smith]
`
`Advanced Search
`
`Recenthistory
`
`Saved searches
`
`Fluorescence characteristics and pharmacokinetic
`properties of a novel self-adhesive 5-ALA patch for
`photodynamic therapyof actinic keratoses.
`
`Fauteck JD", AckermannG,Birkel M, Breuer M, Moor AC,Ebeling A, Ortland C
`
`Author information >
`
`Archives of Dermatological Research, 25 Oct 2007, 300(2) 53-60
`DOI: 10.1007/s00403-007-0787-0
`PMID: 17960406
`
`Sharethis article
`
`vy Of
`
`Abstract
`
`Actinic keratosis (AK) can be treated by photodynamic therapy (PDT), which is becoming a well-established toolin
`dermatology. Normally a precursor of the photosensitiser is applied topically and converted into protoporphyrin IX
`(PPIX) in thecells. By activating PPIX with light, the dysplastic cells will be destroyed. We report the results of two
`clinical studies investigating the properties of a novel self-adhesive 5-ALA-patch (PD P 506 A) intended for PDT of m
`to moderate AK on the face and head. The studies investigated the influence of patch application duration on PPIX-
`specific fluorescence and the pharmacokinetic properties of the 5-ALA patch. The PPIX fluorescencein AK lesions a
`normal skin after patch application (intraindividual comparison; applicationfor 2, 3, 4, 5 h) was investigated in 13
`patients using DYADERM Professional (Biocam). In the subsequent pharmacokinetic study 12 patients were treated
`with 8 patches each (4 h application). 5-ALA and PPIX were analysed in plasma (over 24 h) and urine (over 12 h). PPI
`specific fluorescence measured immediately after patch removal increased with increasing application duration to
`maximumat 4-h application. The fluorescence in AK lesions was moreintense than in normal skin. A small increase
`of 5-ALA plasma concentrations was observed in 10 of 12 patients after applying 8 patches for 4 h, which rapidly
`declined to normalvalues after patch removal. The maximum increase was3.7-fold of the pre-dose 5-ALA plasma
`concentration. No PPIX-concentrations abovethe lowerlimit of quantification were observed. PPIX-specific
`fluorescencein AK lesions can be steered by application duration of this novel 5-ALA patch. Application is safe and
`well tolerable. The observed small rise in 5-ALA plasma concentrationsis regardedclinically irrelevant. Clinical
`efficacy of the patch in PDTwill be investigated in further clinicaltrials.
`
`Full text links
`
`References
`
`Citations & impact
`
`Impact metrics
`
`Biofrontera Exhibit 1034
`This website requires cookies, andthe limited processing of your person:
`eaeee aeneecennchilisetaeed Biofrontera Inc. et al. v. DUSA Pharmaceuticals, Inc.
`
`IPR2022-00056
`
`https://europepmc.org/article/MED/17960406?singleResult=true#impact
`
`

`

` & Signin | Create an account
`
`
`@ Europe PMC About|Tools Developers|Help|Europe PMC plus
`
`
`Search worldwide,life-sciencesliterature
`
`
`
`CITES:17960406_MED
`
`Coronavirus articles and preprints Search examples: "breast cancer" Smith]
`
`Advanced Search
`
`Recenthistory
`
`Saved searches
`
`Fluorescence characteristics and pharmacokinetic
`properties of a novel self-adhesive 5-ALA patch for
`photodynamic therapyof actinic keratoses.
`
`Fauteck JD", AckermannG,Birkel M, Breuer M, Moor AC,Ebeling A, Ortland C
`
`Author information >
`
`Archives of Dermatological Research, 25 Oct 2007, 300(2) 53-60
`DOI: 10.1007/s00403-007-0787-0
`PMID: 17960406
`
`Sharethisarticle
`
`vy Of
`
`Abstract
`
`Actinic keratosis (AK) can be treated by photodynamic therapy (PDT), which is becoming a well-established toolin
`dermatology. Normally a precursor of the photosensitiser is applied topically and converted into protoporphyrin IX
`(PPIX) in thecells. By activating PPIX with light, the dysplastic cells will be destroyed. We report the results of two
`clinical studies investigating the properties of a novel self-adhesive 5-ALA-patch (PD P 506 A) intended for PDT of m
`to moderate AK on the face and head. The studies investigated the influence of patch application duration on PPIX-
`specific fluorescence and the pharmacokinetic properties of the 5-ALA patch. The PPIX fluorescencein AK lesions a
`normal skin after patch application (intraindividual comparison; applicationfor 2, 3, 4, 5 h) was investigated in 13
`patients using DYADERM Professional (Biocam). In the subsequent pharmacokinetic study 12 patients were treated
`with 8 patches each(4 h application). 5-ALA and PPIX were analysed in plasma (over 24 h) and urine (over 12 h). PPI
`specific fluorescence measured immediately after patch removal increased with increasing application duration to
`maximumat 4-h application. The fluorescence in AK lesions was moreintense than in normal skin. A small increase
`of 5-ALA plasma concentrations was observed in 10 of 12 patients after applying 8 patches for 4 h, which rapidly
`declined to normalvalues after patch removal. The maximum increase was3.7-fold of the pre-dose 5-ALA plasma
`concentration. No PPIX-concentrations above the lowerlimit of quantification were observed. PPIX-specific
`fluorescencein AK lesions can be steered by application duration of this novel 5-ALA patch. Application is safe and
`well tolerable. The observed small rise in 5-ALA plasma concentrationsis regarded clinically irrelevant. Clinical
`efficacy of the patch in PDTwill be investigated in furtherclinicaltrials.
`
`Full text links
`
`References
`
`Citations & impact
`
`Impact metrics
`
`By using the site youare agreeing to this as outlinedin ourprivacy notice andcookie policy.
`
`This website requires cookies, andthe limited processing of your personal data in orderto function.
`;
`}
`|
`:
`:
`;
`|
`'
`;
`
`:
`ce
`| agree, dismiss this banner
`
`https://europepmc.org/article/MED/17960406?singleResult=true#impact
`
`

`

`Jump to Citations
`
`Citations of article over time
`
`® Citations
`
`
`
`
`
`2008
`
`2009
`
`2011
`
`2015
`
`2019
`
`Smart citations by scite.ai @
`Explore citation contexts and check ifthis article has been supportedor disputed.
`https://scite.ai/reports/10.1007/s00403-007-0787-0 (7
`
`Supporting @ 1
`Mentioning @ 27
`Contrasting @ 0
`
`Article citations
`
`Smartphonefluorescence imagerfor quantitative dosimetry of protoporphyrin-IX-based
`photodynamic therapyin skin.
`Ruiz AJ, LaRochelle EPM, GunnJR, Hull SM, Hasan T, Chapman MS, Pogue BW
`J Biomed Opt, 25(6):1-13, 01 Dec 2019
`Cited by: 1 article | PMID: 31820594 | PMCID: PMC6901011
`Free to read & use
`
`
`Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond
`equally well to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
`Szeimies RM, Hauschild A, Ortland C, Moor AC, Stocker M, Surber C
`Br J Dermatol, 173(5):1277-1279, 26 Aug 2015
`Cited by: 3 articles | PMID: 25940103
`
`PpIX fluorescence combined with auto-fluorescence is more accurate than PpIX fluorescence alone
`in fluorescence detection of non melanoma skin cancer an intra patient direct comparison study
`van der Beek N de Leeuw) Demmendal C Bjerring P Neumann HA
`Lasers Surg Med,44(4):271-276, 13 Dec 2011
`Cited by: 6 articles | PMID: 22170313
`
`New aspects in photodynamic therapyof actinic keratoses.
`Smits T, Moor AC
`J Phietarhein Etesnbiel B 96(3) 159 169 13 Jun 2009
`Cited by 5 articles | PMID 19592269
`Review”
`
`
`An overview of topical photodynamic therapyin dermatology.
`Ibbotson SH
`Photodiagnosis Photod
`
`lyn Ther, 7(1):16-23, 29 Dec 2009
`MID
`
`Abstract
`Full text 7
`References
`
`Citations & impact
`Similar Articles
`
`20230989
`
`This website requires cookies, andthe limited processing of your personal data in orderto function.
`,
`;
`;
`on
`By using the site youare agreeing to this as outlinedin ourprivacy notice and cookie
`policy.
`
`5
`TT
`| agree, dismiss this banner
`
`https://europepmc.org/article/MED/17960406?singleResult=true#impact
`
`

`

`About
`About Europe PMC
`Funders
`Joining Europe PMC
`Governance
`Roadmap
`Outreach
`
`Similar Articles
`
`Tools
`Tools overview
`ORCIDart cle da m ng
`Journallist
`Grant finder
`External links service
`RSS feeds
`Annotations
`Annotat ons subm ss on serv ce
`
`Developers
`Developer resources
`Art cles RESTful API
`Grants RESTful API
`API case stud es
`SOAP webservice
`Annotat ons API
`OAIservice
`Bulk downloads
`Developers Forum
`
`Help
`Help using Europe PMC
`Search synta_ reference
`Contact us
`
`Fe
`Th
`
`Te
`
`Letu know how weare doing
`
`
`
`Europe PMC is partof the ELIXIR infrastructure
`re Data R
`«
`nm
`Europe PMCis an ELD
`
`Europe PMCis a service of the Europe PMC Funders’ Group, in partnership with the European BioinformaticsInstitute ; and in cooperation with the National Center for Biotechnology Information €
`includes content provided to the PMCInternationalarchive by participating publishers.
`Y & ¥ oe
`Contact us | Privacy | Termsof use | Copyright | Accessibility
`
`| agree, dismiss this banner
`
`This website requires cookies, and the limited processing of your personal data in orderto function.
`By using the site youare agreeing to this as outlined in ourprivacy notice and cookie policy.
`
`https://europepmc.org/article/MED/17960406?singleResult=true#impact
`
`

`

`& Sign in|Create an account|
`
`About
`
`Tools
`
`Developers
`
`Help
`
`Europe PMC plus
`
`Search worldwide,life-sciencesliterature
`
`
`
`CITES:17960406_MED
`
`Q Search
`
`Advanced Search
`
`Coronavinisarticlesandpreprints
`
`Search examples: “breastcancer” Smith}
`
`Recenthistory
`
`Saved searches
`
`1-9 of 9 results
`
`
`
`Sort by:|Date received ’
`
`Search only
`
`Type @
`O Researcharticles (7)
`O Reviews (2)
`
`Preprints (0)
`
`Free full text ®
`
`O Free to read (1)
`O Free to read & use (1)
`
`Date
`
`O 2019 «1
`
`O 2015 a1)
`
`O 2011 «1
`
`Custom date range >
`
`Smartphone fluorescence imager for quantitative dosimetry of protoporphyrin-|X-based photodynamic the
`in skin.
`
`Ruiz AJ, LaRochelle EPM, GunnJR, Hull SM, Hasan T, Chapman MS, Pogue BW
`J Biomed Opt, 25(6):1-13, 01 Dec 2019
`Cited by:1 article | PMID: 31820594 | PMCID: PMC6901011
`
`+ Add to export list Free to read &
`
`Photodynamic therapy simplified: nonprepared, moderate-grade actinic keratosis lesions respond equally '
`to 5-aminolaevulinic acid patch photodynamic therapy as do mild lesions.
`Szeimies RM, Hauschild A, Ortland C, Moor AC, Stocker M, Surber C
`Br J Dermatol, 173(5):1277-1279, 26 Aug 2015
`Cited by: 3 articles | PMID: 25940103
`+ Add to export list
`
`PpIX fluorescence combined with auto-fluorescence is more accurate than PpIX fluorescence alonein
`fluorescence detection of non-melanomaskin cancer: an intra-patient direct comparison study.
`van der Beek N, de Leeuw J, DemmendalC, Bjerring P, Neumann HA
`Lasers Surg Med, 44(4):271-276, 13 Dec 2011
`Cited by: 6 articles | PMID: 22170313
`+ Add to export list
`
`Anoverview of topical photodynamic therapy in dermatology.
`Ibbotson SH
`
`Photodiagnosis Photodyn Ther, 7(1):16-23, 29 Dec 2009
`Cited by: 17 articles | PMID: 20230989
`
`+ Add to export list Rev
`
`Long-term follow-up of photodynamic therapywith a self-adhesive 5-aminolaevulinic acid patch: 12 month
`data.
`
`Szeimies RM, Stockfleth E, Popp G, Borrosch F, Briining H, Dominicus R, Mensing H, Reinhold U, Reich K, Moor é
`Stocker M, Ortland C, Brunnert M, Hauschild A
`Br J Dermatol, 162(2):410-414, 30 Jun 2009
`Cited by:26 articles | PMID: 19804593
`+ Add to export list
`
`New aspects in photodynamic therapyof actinic keratoses.
`Smits T, Moor AC
`J Photochem PhotobiolB, 96(3):159-169, 13 Jun 2009
`Cited by: 5 articles | PMID: 19592269
`+ Add to export list
`
`Rev
`
`This website requires cookies, and the limited processing of your personal data in order to function.
`By using the site you are agreeingto this as outlined in our privacy notice and cookie policy.
`
`| agree, dismiss this banner
`
`https://europepmc.org/search?query=CITES%3A17960406_MED&page=1 &sortby=Date DESC
`
`004
`
`

`

`Lasers Surg Med, 41(2):96-103, 01 Feb 2009
`Cited by: 21 articles | PMID: 19226578
`+ Add to export list
`
`Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of t
`randomized controlled phaseIII studies.
`Hauschild A, Stockfleth E, Popp G, Borrosch F, Briining H, Dominicus R, Mensing H, Reinhold U, Reich K, Moor A
`Stocker M, Ortland C, Brunnert M, Szeimies RM
`Br J Dermatol, 160(5):1066-1074, 16 Feb 2009
`Cited by: 39 articles | PMID: 19222455
`+ Add to export list
`
`Effective photodynamic therapyofactinic keratoses on the head andface with a novel, self-adhesive 5-
`aminolaevulinic acid patch.
`Hauschild A, Popp G, Stockfleth E, Meyer KG, Imberger D, MohrP, Itschert G, Kaufmann R, NeuberK, Frambach
`Gollnick H, Brunnert M, Stocker M, Ortland C, KarrerS
`Exp Dermatol, 18(2):116-121, 17 Jul 2008
`Cited by: 21 articles | PMID: 18643849
`+ Add to export list
`
`About
`About Europe PMC
`Funders
`Joining Europe PMC
`Governance
`Roadmap
`Outreach
`
`1-9 of 9 results
`
`Tools
`Tools overview
`ORCID article claiming
`Journal list
`Grantfinder
`Externallinks service
`RSS feeds
`Annotations
`Annotations submission service
`
`Developers
`Developer resources
`Articles RESTful API
`Grants RESTful API
`API case studies
`SOAP webservice
`Annotations API
`OAIservice
`Bulk downloads
`Developers Forum
`
`Let us know how weare doing.
`
`Europe PMC is part of the ELIXIR infrastructure
`Europe PMC is an ELIXIR Core Data Resource Learn more >
`
`Help
`Help using Europe PMC
`Search syntax reference
`Contact us
`
`Cc
`Hi
`Fe
`WV
`Bl
`Te
`Di
`
`Europe PMCisaservice of the Europe PMC Funders’ Group, in partnership with the European Bioinformatics Institute ; and in cooperation with the National Center for Biotechnology Information a
`includes content provided to the PMCInternational archive by participating publishers.
`YY & ¥v¥ Oo
`Contact us | Privacy | Terms of use | Copyright | Accessibility
`
`This website requires cookies, and the limited processing of your personal data in order to function.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`-
`By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.
`
`| agree, dismiss this banner
`
`https://europepmc.org/search?query=CITES%3A17960406_MED&page=1 &sortby=Date DESC
`
`005
`
`